You are here

Analysis: The FDA's controversial strategy for evaluating new COVID boosters

Primary tabs

Thu, 2022-08-18 14:05 — mike kraft

What's behind the FDA's controversial strategy for evaluating new COVID boosters Some scientists are alarmed that the agency plans to evaluate the next generation of boosters by reviewing mouse studies alone. Others say there's no time to waste waiting for human trials. NPR.org

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Groups this Group Post belongs to:

- Private group -

Log in or register to post comments

Page loaded in 0.459 seconds.